Noveris Health Sciences is trading at CA$0.04, with a -18.18% session move; biotech-sector weakness offers context, but no direct catalyst is confirmed.
- No company-specific announcement for October 23 appears in its news list; its latest listed release is dated September 9.
- Supplied sector data shows XBI down 2.08% in the session, and a market update also reported biotechnology shares lower.